Cost
$1,500 per cycle - $4,500 per cycle
Procedure Type:
Medical Management
Hospitalization Days:
Day-care procedure
Procedure Duration:
minutes to hours
Success Rate:
40-70%
Cancer treatment has evolved significantly, and Immunotherapy is one of the biggest breakthroughs in modern oncology. Instead of killing cancer cells directly like chemotherapy, immunotherapy strengthens the body’s own immune system to detect and destroy cancer cells more effectively and with fewer side effects.
Immunotherapy in India has gained global attention because India offers the same advanced drugs, such as Pembrolizumab, Nivolumab, Atezolizumab, and Durvalumab, used in the US and Europe, but at significantly lower costs. With cutting-edge oncology centers, experienced medical oncologists, molecular diagnostics, and multidisciplinary cancer programs, India is now a leading destination for international patients looking for affordable and personalized cancer care. The cost of immunotherapy in India ranges from USD 1,500 to USD 4,500 per cycle.
Immunotherapy is a cancer treatment that boosts or modifies the immune system to attack cancer cells more efficiently.
How immunotherapy works:
It is particularly effective for cancers like lung cancer, melanoma, kidney cancer, breast cancer, bladder cancer, lymphoma, and certain head & neck cancers.
The type of immunotherapy recommended depends on the cancer’s genetic profile, stage, and behavior. Different immunotherapies work in different ways; some activate immune cells, while others remove the “invisibility cloak” cancer uses.
Immunotherapy is not for everyone; doctors evaluate the cancer type, biomarkers, and the patient’s health. Eligibility depends mainly on whether the tumor expresses certain proteins like PD-L1 or has a high mutation load.
You may be a candidate if:
Biomarker testing guides whether immunotherapy will respond effectively.
Immunotherapy is not a surgery, but a diagnostic evaluation is essential. Immunotherapy requires detailed testing to determine whether it will be effective. They help doctors choose the right drug and predict response.
Common evaluations include:
These tests ensure accurate, personalized treatment planning.
Immunotherapy packages in India vary depending on the drug used and the number of cycles. They typically include consultations, drug costs, and day-care services.
Typically included:
Not included:
Packages help patients understand cycle-wise costs clearly.
India has rapidly become a leading destination for advanced oncology treatments like immunotherapy. India offers global-standard immunotherapy at costs up to 70% lower than in the West, without compromising quality.
Why international patients choose India:
India combines innovation, expertise, and affordability, making it one of the best choices for cancer immunotherapy globally.
International patients undergoing cancer treatment often require long-term visits. Indian medical facilitators like NeuHealth Trips ensure smooth coordination throughout the journey. Regular cycles and follow-ups require hassle-free planning.
These services ensure a stress-free, well-planned treatment experience for international patients.
Immunotherapy costs in India depend on the drug, cancer type, and number of cycles required. The cost of the drug itself contributes to 80-90% of the total treatment expense. The cost of immunotherapy in India ranges from USD 1,500 to USD 4,500 per cycle.
Typical drug-wise costs:
Even with costly globally approved immunotherapy drugs, India remains much more affordable than Western countries.
Transparent · Professional · Without Hassles
Book Doctor Appointment
Consult on Video or in-person at Hospital
Compare Cost Estimates
Hospitalisation Support
Many clinical and treatment factors affect the final cost of immunotherapy. Different cancers require different drugs, dosages, and cycle durations.
Cost-influencing factors include:
Personalized treatment planning determines the exact cost for each patient.
India offers the same FDA-approved immunotherapy drugs as the West, at dramatically lower costs. Patients save thousands of dollars per cycle by choosing India.
| Country | Immunotherapy Cost (per cycle) |
| India | USD 1,500 - USD 4,500 |
| USA | USD 8,000 - USD 20,000 |
| UK | USD 6,000 - USD 12,000 |
| UAE | USD 5,000 - USD 10,000 |
| Singapore | USD 6,000 - USD 15,000 |
| Turkey | USD 2,500 - USD 6,000 |
India remains one of the world’s most cost-effective destinations for immunotherapy.
Immunotherapy is usually given in a day-care facility without hospital admission. The process is simple: testing → infusion → observation.
Immunotherapy is minimally invasive and easy to integrate into daily life.
Recovery is gradual and differs from chemotherapy. Side effects are generally milder, but immune-related reactions must be monitored closely.
Proper monitoring ensures early detection of side effects and maximizes treatment effectiveness.
Reach out to us today for a free consultation and customized treatment plan.
Our services are FREE and by using our services your hospital bill does not increase!
Immunotherapy boosts your immune system so it can find and attack cancer cells more effectively. It teaches your body to recognize cancer as a threat and fight it naturally.
Most infusions take between 30 minutes and 2 hours, depending on the drug. Afterward, patients are observed briefly and can return home the same day.
Lung cancer, melanoma, lymphoma, bladder cancer, kidney cancer, and some breast cancers respond particularly well. Doctors choose the treatment based on your tumor’s biomarkers.
Generally, yes. Patients experience less nausea, hair loss, and fatigue, though some immune-related reactions may still occur and need timely monitoring.
Most patients begin to see improvement after 2 to 3 treatment cycles. Follow-up scans every few months help measure progress.
Yes, many treatment plans successfully combine both. This can increase the overall effectiveness, especially in lung and breast cancers.
Often, yes. As long as overall health is stable, older patients can receive immunotherapy with good tolerance and encouraging results.
Usually yes. Tests like PD-L1, MSI, and TMB help doctors understand whether your cancer will respond well to immunotherapy drugs.
Patients are usually seen before each cycle for blood tests and symptom checks. Scans every 8 to 12 weeks help track progress and adjust treatment if needed.
Yes, India offers all major FDA-approved immunotherapy drugs at more affordable prices. This makes high-quality cancer care accessible to more patients worldwide.
